Results 11 to 20 of about 540,096 (367)
Pediatrics & Neonatology, 2018 Neonatal tumors are different from tumors of the older children and knowledge gained from treating older children can not be extrapolated to neonates. Neonates have immature physiology and their haematopoietic and immune systems are not fully developed and the response to therapy is unpredictable.
Aravindan Chandrasekaran
openaire +4 more sources
Table_1_Therapeutic exercise interventions in pediatric survivors of brain cancer and other solid tumors: A scoping review.pdf [PDF]
, 2022 BackgroundImproved survival rates for children with solid tumors presents an ongoing challenge of how to maximize quality of survivorship and effectively manage the short- and long-term complications of disease and treatment.
Sandler, Carolina X +14 more
core +1 more source
t(12;15)(p13;q25) ETV6/NTRK3 in solid tumors [PDF]
, 2020 Review on t(12;15)(p13;q25) in solid tumors, with data on clinics, and the genes ...
Huret, Jean-Loup
core +1 more source
MicroRNAs in Solid Tumors [PDF]
Journal of Surgical Research, 2009 MicroRNAs (miRNAs or miRs) are small, noncoding RNAs (approximately 20-22 nucleotides) that have critical functions in cell proliferation, apoptosis, and differentiation. These evolutionarily conserved RNA sequences are the result of a complex sequence of processing steps, which can regulate the expression of tens, and even hundreds, of genes.
Mary, Dillhoff +2 more
openaire +2 more sources
Chronotherapeutics for Solid Tumors
Pharmaceutics, 2023 Circadian rhythms are internal manifestations of the 24-h solar day that allow for synchronization of biological and behavioral processes to the external solar day. This precise regulation of physiology and behavior improves adaptive function and survival.
Claire O. Kisamore +4 more
openaire +3 more sources
Metastasis and Tumor Cell Migration of Solid Tumors [PDF]
Cancers, 2021 The developmental process of local and distant metastases represents the major and defining trait of malignant tumors, whereby tumor cells sustain the capability to migrate from the initial tumor site, seed, and grow at a location other than that of the initial tumor [...]
Jens Hoeppner, Peter Bronsert
openaire +3 more sources
Numerical simulation of solid tumor blood perfusion and drug delivery during the “vascular normalization window” with antiangiogenic therapy [PDF]
, 2011 This Article is provided by the Brunel Open Access Publishing Fund - Copyright @ 2011 Hindawi PublishingTo investigate the influence of vascular normalization on solid tumor blood perfusion and drug delivery, we used the generated blood vessel network ...
Long, Q +13 more
core +1 more source
Journal for ImmunoTherapy of Cancer, 2019 Growing evidence suggests a clear role of the host immune system in HER2+ breast cancer. In addition, HER2+ breast cancer is generally considered more immunogenic than hormone receptor-positive (HR+)/HER2-, and specific molecular HER2+ subgroups (e.g ...
Gaia Griguolo +4 more
doaj +1 more source
Nature Communications, 2023 Drug combinations are key to circumvent resistance mechanisms compromising response to single anti-cancer targeted therapies. The implementation of combinatorial approaches involving MEK1/2 or KRASG12C inhibitors in the context of KRAS-mutated lung ...
Irati Macaya +31 more
doaj +1 more source